Subcutaneous interleukin-4 for relapsed non-Hodgkin's lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.

被引：0
|
作者：
Kurtz, D. M. [1 ]
Tschetter, L. K. [1 ]
Allred, J. B. [1 ]
Geyer, S. M. [1 ]
Kurtin, P. J. [1 ]
Putnam, W. D. [1 ]
Rowland, K. M. [1 ]
Wiesenfeld, M. [1 ]
Soori, G. S. [1 ]
Tenglin, R. C. [1 ]
Bernath, A. M. [1 ]
Witzig, T. E. [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2007年 / 55卷 / 02期
关键词：
D O I：
10.1097/00042871-200703010-00088
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
81
引用
收藏
页码：S362 / S362
页数：1
相关论文
共 50 条
  • [31] Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group Trial 9246
    Press, OW
    LeBlanc, M
    O'Rourke, TJ
    Gagnet, S
    Chapman, RA
    Balcerzak, SP
    Fisher, RI
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 574 - 578
  • [32] Final results of the phase II trial of paclitaxel plus oral estramustine phosphate in patients with relapsed aggressive non-Hodgkin's Lymphoma.
    Borghaei, H
    Millenson, MM
    Schilder, RJ
    Rogatko, A
    Alden, M
    Wang, H
    Padavic-Shaller, KA
    Minnitti, C
    Smith, MR
    BLOOD, 2003, 102 (11) : 293B - 293B
  • [33] An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma
    Witzig, T. E.
    Vose, J. M.
    Zinzani, P. L.
    Reeder, C. B.
    Buckstein, R.
    Polikoff, J. A.
    Bouabdallah, R.
    Haioun, C.
    Tilly, H.
    Guo, P.
    Pietronigro, D.
    Ervin-Haynes, A. L.
    Czuczman, M. S.
    ANNALS OF ONCOLOGY, 2011, 22 (07) : 1622 - 1627
  • [34] Anti-tumor activity of mTOR inhibitor temsirolimus for relapsed mantle cell lymphoma: A phase II trial in the North Central Cancer Treatment Group.
    Ansell, S. M.
    Geyer, S. M.
    Kurtin, P. J.
    Inwards, D. J.
    Kaufmann, S. H.
    Flynn, P. J.
    Morton, R. F.
    Luyun, R. F.
    Dakhil, S. R.
    Gross, H.
    Witzig, T. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 430S - 430S
  • [35] A phase I/II trial to evaluate the immunogenicity of recombinant idiotype protein vaccines for the treatment of non-Hodgkin's lymphoma (NHL).
    Timmerman, J
    Czerwinski, D
    van Beckhoven, A
    Vose, J
    Ingolia, D
    Kunkel, L
    Denney, D
    Levy, R
    BLOOD, 2000, 96 (11) : 578A - +
  • [36] Phase II trial of didemnin B in previously treated non-Hodgkin's lymphoma - An Eastern Cooperative Oncology Group (ECOG) study
    Kucuk, O
    Young, ML
    Habermann, TM
    Wolf, BC
    Jimeno, J
    Cassileth, PA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (03): : 273 - 277
  • [37] Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: A north central cancer treatment group (NCCTG) phase i and II trial, N9943
    Alberts S.R.
    Sande J.R.
    Foster N.R.
    Quevedo F.J.
    McWilliams R.R.
    Kugler J.W.
    Fitch T.R.
    Jaslowski A.J.
    Journal of Gastrointestinal Cancer, 2007, 38 (2-4) : 87 - 94
  • [38] Two consecutive phase II studies of oxaliplatin based salvage chemotherapy for treatment of patients with refractory or relapsed non-Hodgkin's lymphoma.
    Delmas-Marsalet, B
    Gumus, Y
    Misra, S
    Goldschmidt, E
    Frenoy, N
    Guettier, C
    Brahimi, N
    Ulusakarya, A
    Jasmin, C
    Machover, D
    BLOOD, 2002, 100 (11) : 297B - 297B
  • [39] Liposomal daunorubicin (Daunoxome) in relapsed/refractory AIDS-related non-Hodgkin's lymphoma (AIDS-NHL): A phase II trial.
    Tulpule, A
    Dezube, BJ
    Doweiko, J
    Espina, BM
    Proper, J
    Cabriales, SL
    Levine, AM
    BLOOD, 1999, 94 (10) : 526A - 526A
  • [40] Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: Phase II trial of the north central cancer treatment group
    Dy, Grace K.
    Jett, James R.
    Geoffroy, Francois J.
    Krewer, Keith D.
    Tazelaar, Henty
    Maurer, Matthew
    Rowland, Kendrith
    Mailliard, James
    Krook, James
    Dakhil, Shaker
    Kutteh, Leila
    Kugler, John
    Wender, Donald
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (03) : 211 - 217
12345